focus -WSS

focus

author：entertainment 2025-09-27 09:46:12 - browse：8747

The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

“It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Orangutan used medicinal plant to treat wound, first time ever seen

hotspot

WSS

Sanofi seeks simpler, safer CRISPR sickle cell cure

Listen: Wegovy in the brain & pivotal Alzheimer's data

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

How Medicaid coverage policies for immigrants impact new moms

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Google and Epic fight stronger regulation of AI in health care

explore

focus

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Cell therapy fails to slow type 1 diabetes, but safety is established

Guidelines to prevent youth baseball injuries need more muscle

How Medicaid coverage policies for immigrants impact new moms

Medicare proposal to cover medical devices draws a mixed reaction

Startup Neumora takes a novel depression drug to Phase 3

Hepatitis C has a cure — but many Americans still lack access to it

Doctors find melanoma drugs effective against rare brain cancer

Medical records are filled with copy

Getting Alzheimer's drug Leqembi to patients can be a challenge

knowledge

Health care needs a new profession: neuroimaging counseling

Element Biosciences CEO lays out genome sequencing strategy

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Health care needs a new profession: neuroimaging counseling

More tobacco lobbyists active in statehouses

In early work, researchers turn to CRISPR to treat Alzheimer's

hotspot

focus

hotspot

Wikipedia